Gabon
Africa, Central
Hemorrhagic Fever, Ebola
Mandrillus
Loiasis
Ebolavirus
Malaria, Falciparum
CYP2D6 polymorphism in a Gabonese population: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype. (1/246)
AIMS: To determine the molecular basis of the intermediate extensive metaboliser (EM) CYP2D6 phenotype in healthy Gabonese subjects. METHODS: The CYP2D6 phenotype of 154 healthy Gabonese subjects was assessed by giving the subject a single dose of 30 mg dextromethorphan, and collecting their urine for the next 8 h. The CYP2D6 genotype was determined for 50 individuals of the EM phenotypic group by Southern blotting and various PCR-based procedures aimed at identifying different CYP2D6 alleles. RESULTS: We found that in the studied Gabonese population, as compared with a French population, there is significantly higher frequency of intermediate EM phenotype having lower frequency of CYP2D6 PM alleles. To clarify this discrepancy phenotype-genotype relationship was studied. We found that the CYP2D6*17 and CYP2D6*2 alleles, prevalent in this black population, are characterised by their low capacity for dextromethorphan demethylation. Our data also show that the CYP2D6*1 allele is associated with the highest in vivo activity followed by the CYP2D6*2 allele and then the CYP2D6*17 allele. CONCLUSIONS: The higher frequencies of the CYP2D6*2 and CYP2D6*17 alleles than the CYP2D6*1 allele account for the high frequency of the intermediate EM phenotype in this black population. The polymorphism of the CYP2D6 enzyme activity in African populations could have important implications for use of drugs that are substrates for CYP2D6 and have a narrow therapeutic window. (+info)High oxygen radical production is associated with fast parasite clearance in children with Plasmodium falciparum malaria. (2/246)
It has been hypothesized that reactive oxygen intermediates (ROI) released by leukocytes play a major role in the immune response to many infectious agents. In the present study, the parasitologic and clinical courses of 75 Gabonese children with Plasmodium falciparum malaria were compared with the ability of their granulocytes to produce oxygen radicals. The luminol-dependent chemiluminescence in granulocyte suspensions for the children was measured without stimulation and after stimulation with phorbol-12-myristate-13-acetate, N-formyl-methionyl-leucyl-phenylalanine, or tumor necrosis factor. A significant association was found between fast parasite clearance time and high oxygen radical generation in both the unstimulated and stimulated granulocyte preparations. No correlation was found between fever clearance time and ROI generation. These findings suggest that ROI play a pivotal role in the immune response as a first line of defense against P. falciparum malaria. (+info)Leptospirosis and Ebola virus infection in five gold-panning villages in northeastern Gabon. (3/246)
An exhaustive epidemiologic and serologic survey was carried out in five gold-panning villages situated in northeastern Gabon to estimate the degree of exposure of to leptospirosis and Ebola virus. The seroprevalence was 15.7% for leptospirosis and 10.2% for Ebola virus. Sixty years after the last seroepidemiologic survey of leptospirosis in Gabon, this study demonstrates the persistence of this infection among the endemic population and the need to consider it as a potential cause of hemorrhagic fever in Gabon. There was no significant statistical correlation between the serologic status of populations exposed to both infectious agents, indicating the lack of common risk factors for these diseases. (+info)Relationships between malaria prevalence and malaria-related morbidity in school children from two villages in central Africa. (4/246)
To investigate the relationship between parasite prevalence and malaria-related morbidity, we carried out a comparative study among cohorts of school children from two villages, Dienga, Gabon, and Pouma, Cameroon, both located in malaria-endemic areas. Seven to 17 year-old children attending primary schools were similarly followed-up at each site to evaluate the frequency of malaria attacks. Follow-up involved daily temperature recording (and blood smears in the case of fever) and preparation of blood smears every two weeks. In Pouma, 186 children were followed-up for six months. In Dienga, 228 children were followed-up for nine months. The mean prevalence rate of Plasmodium falciparum infections (as assessed by the blood smears) was twice as high in Pouma compared with Dienga (45.2% versus 26.8%; P < 0.0001), whereas the monthly malaria attack rate (as assessed by the daily surveillance) was twice as high in Dienga compared with Pouma (21.5% versus 41.4%; P = 0.003). The possible implication of several parameters that may differ between the two areas, such as the malaria transmission level, the economical and social status of the inhabitants, the characteristics of infecting parasite strains, and the genetic background of the population, is discussed. (+info)Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria. (5/246)
Plasmodium falciparum malaria is an important cause of morbidity and mortality in children. Factors that determine the development of mild versus severe malaria are not fully understood. Since host-derived nitric oxide (NO) has antiplasmodial properties, we measured NO production and NO synthase (NOS) activity in peripheral blood mononuclear cells (PBMC) from healthy Gabonese children with a history of prior mild malaria (PMM) or prior severe malaria (PSM) caused by P. falciparum. The PMM group had significantly higher levels of NOS activity in freshly isolated PBMC and higher NO production and NOS activity in cultured PBMC. The investigation of NO-modulating cytokines (e.g., interleukin 12, gamma interferon, tumor necrosis factor alpha [TNF-alpha], and transforming growth factor beta1) as an explanation for differing levels of NOS activity revealed that plasma levels of TNF-alpha were significantly higher in the PSM group. Our results suggest that NOS/ NO and TNF-alpha are markers for prior disease severity and important determinants of resistance to malaria. (+info)Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children. (6/246)
The frequency and level of cellular and humoral responses to seven synthetic peptides from asexual blood stages of Plasmodium falciparum were measured in two cohorts of children living in areas highly endemic for malaria in Gabon and Cameroon. A prospective longitudinal study was conducted for one year in these sites to examine the relationship between specific in vitro immune responses and susceptibility to clinical malaria. Clinical protection was related to high proliferative responses (merozoite surface antigen-1 [MSA-1] and MSA-2 peptides) as well as to elevated antibody levels (schizont extract, MSA-2, and rhoptry-associated protein-1 [RAP-1] peptides) in the village of Dienga, Gabon. Higher response rates of interferon-gamma but lower response rates of tumor necrosis factor-alpha to four and six peptides, respectively, were observed in Dienga than in Pouma that were independent of the older age of the Gabonese children. Age accounted only for the higher prevalence rate in Dienga of the antibody responders to the peptide from Pf155/ring-infected erythrocyte surface antigen (RESA). Our results support the inclusion of epitopes from MSA-1, MSA-2, RAP-1, and Pf155/RESA antigens in a subunit vaccine against malaria, but show that a longitudinal clinical, parasitologic, and immunologic study conducted according to identical criteria in two separate areas may lead to contrasting observations, demonstrating the geographic limitation of the interpretation of such results. (+info)Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambarene, Gabon. (7/246)
The intercellular adhesion molecule-1 (ICAM-1) is thought to be a receptor that mediates binding of Plasmodium falciparum-infected erythrocytes. Especially in vital organs, the binding of parasitized cells to the endothelium via ICAM-1 may lead to severe disease and death. Recently, a mutation in the coding region of ICAM-1, termed ICAM-1Kilifi, was described, causing a change from Lys to Met in the loop that interacts with rhinoviruses, lymphocytes, and parasitized red blood cells. Surprisingly, this mutation was shown to increase susceptibility of Kenyan children to severe malaria in one study. When we compared the distribution of ICAM-1Kilifi in two groups of Gabonese children enrolled in a case-control, matched-pair study who presented with either mild or severe malaria, we found that 55% of the patients with mild malaria were carriers whereas only 39% of those with severe malaria were carriers. The difference in the distribution of ICAM-1Kilifi homozygous pairs between the groups, as well as the distribution of ICAM-1Kilifi carriers, was statistically highly significant (P = 0.027 and P = 0.012, by the McNemar test). In a group of healthy school children from the same region, a distribution of 52% ICAM-1Kilifi carriers to 48% wild-type individuals was found. In a survey for the ICAM-1Kilifi in other malaria-endemic regions, this allele was also found in Nigeria and Papua New Guinea, but not in Thailand. (+info)Factors influencing resistance to reinfection with Plasmodium falciparum. (8/246)
A treatment-reinfection study design was used to investigate the relationships between host immunologic and/or genetic factors and resistance to reinfection with Plasmodium falciparum. Sixty-one children in Gabon were enrolled in a cross-sectional study to measure the prevalence of each human plasmodial species. All were given amodiaquine for radical cure of parasites, and 40 were subsequently followed-up for 30 weeks. Successive blood smears were examined to measure the delay of reappearance in blood of asexual stages of P. falciparum parasites. Presence of infection during the cross-sectional survey was associated with male sex, non-deficient glucose-6-phosphate dehydrogenase activity, plasma interleukin-10 level, and anti-LSA-Rep antibody concentration. Resistance to reinfection was related to the presence of anti-LSA-J antibodies, and the absence of anti-LSA-Rep antibodies. Moreover, P. malariae-infected subjects were usually co-infected with P. falciparum, and were also more rapidly reinfected with P. falciparum after treatment, compared with those without P. malariae infection. (+info)I'm sorry for any confusion, but "Gabon" is not a medical term. It is the name of a country located in Central Africa, known officially as the Gabonese Republic. If you have any questions about medical terminology or health-related topics, I would be happy to help with those!
Central Africa is a geographical region that broadly includes the countries that lie near the equator and are found in the interior of the African continent. The United Nations defines Central Africa as consisting of the following countries: Angola, Burundi, Cameroon, Central African Republic, Chad, Democratic Republic of the Congo, Republic of the Congo, Equatorial Guinea, Gabon, Rwanda, and Sao Tome and Principe.
The region is characterized by diverse cultures, languages, and landscapes, ranging from dense rainforests to vast savannas. Central Africa is home to many important rivers, including the Congo River, which is the second longest river in Africa and the deepest river in the world. The region also contains numerous national parks and wildlife reserves that protect a diverse array of plant and animal species, including several endangered species such as mountain gorillas, chimpanzees, and forest elephants.
Central Africa faces many challenges, including political instability, poverty, and environmental degradation. The region has been plagued by conflicts and civil wars, which have resulted in significant loss of life, displacement of people, and destruction of infrastructure. Climate change and deforestation are also major concerns, as they threaten the region's biodiversity and contribute to global warming.
In terms of healthcare, Central Africa faces many challenges, including a high burden of infectious diseases such as HIV/AIDS, malaria, tuberculosis, and Ebola. Access to healthcare is limited in many areas, particularly in rural communities, and there is a shortage of healthcare workers and medical facilities. In addition, the region has been affected by conflicts and humanitarian crises, which have further strained healthcare systems and made it difficult to provide adequate care to those in need.
Ebola Hemorrhagic Fever (EHF) is a severe, often fatal illness in humans. It is one of the five identified subtypes of the Ebolavirus. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission.
The early symptoms include sudden onset of fever, fatigue, muscle pain, headache and sore throat. This is followed by vomiting, diarrhea, rash, symptoms of impaired kidney and liver function, and in some cases, both internal and external bleeding.
Laboratory findings include low white blood cell and platelet counts and elevated liver enzymes.
The virus is introduced into the human population through close contact with the blood, secretions, organs or other bodily fluids of infected animals such as fruit bats, porcupines and non-human primates. Then it spreads in communities through human-to-human transmission via direct contact (through broken skin or mucous membranes) with the blood, secretions, organs or other bodily fluids of infected people, and with surfaces and materials contaminated with these fluids.
Healthcare workers have frequently been infected while treating patients with suspected or confirmed EVD due to a lack of adequate infection prevention and control measures.
There are currently no approved specific antiviral drugs or vaccines for Ebola. Several promising treatments and vaccine candidates are being evaluated.
I'm not aware of a specific medical term called "Ape diseases." However, many primates, including apes, can suffer from diseases that are similar to those that affect humans. Some examples include:
1. Tuberculosis (TB): Both humans and apes can be infected with this bacterial disease, which primarily affects the lungs but can also impact other parts of the body.
2. Hepatitis: Apes can contract various forms of hepatitis, such as hepatitis B and C, just like humans. These viral infections affect the liver and can cause acute or chronic illness.
3. Respiratory infections: Both apes and humans are susceptible to respiratory infections caused by bacteria, viruses, or fungi.
4. Gastrointestinal diseases: Apes can suffer from gastrointestinal issues, such as diarrhea, due to various bacterial, viral, or parasitic infections.
5. Retroviral infections: Some apes are known to be infected with retroviruses, like simian immunodeficiency virus (SIV), which is similar to human immunodeficiency virus (HIV). SIV can lead to a condition called simian AIDS in apes.
6. Zoonotic diseases: Apes can contract zoonotic diseases, which are transmitted from animals to humans, such as Ebola and Marburg viruses.
7. Cardiovascular diseases: Apes can develop heart conditions similar to those seen in humans, including hypertension and atherosclerosis.
8. Neurological disorders: Some apes may suffer from neurological issues, like Parkinson's disease or Alzheimer's disease, although research on these topics is still ongoing.
It's important to note that while apes can contract many of the same diseases as humans, there are also numerous diseases specific to each species due to differences in genetics, environment, and behavior.
"Mandrillus" is a genus of primates that includes two species: the mandrill (M. sphinx) and the drill (M. leucophaeus). These Old World monkeys are native to the rainforests of central Africa, particularly in Cameroon, Gabon, Equatorial Guinea, and Congo.
Mandrills are known for their distinctive appearance, with males having brightly colored faces and rear ends. They are also the largest and most sexually dimorphic monkeys, with males being significantly larger and more brightly colored than females.
Mandrills are primarily frugivorous, feeding on a diet that consists mainly of fruits, but they also eat other plant materials, insects, and occasionally small vertebrates. They live in large, hierarchical groups called troops, which can consist of several hundred individuals.
Mandrills have a complex social structure, with males competing for dominance and access to females. They are known for their loud, distinctive calls, which can be heard up to a mile away and are used to communicate with other members of their troop.
Overall, Mandrillus species are important indicators of the health and diversity of tropical rainforests in central Africa, and they play a critical role in seed dispersal and forest regeneration.
Loiasis is a tropical parasitic infection caused by the filarial nematode worm, Loa loa. It is also known as "African eye worm" due to the migration of the adult worm through the subconjunctival tissues of the eye, which is a common symptom. The infection is transmitted through the bite of deerfly or mango fly (Chrysops spp.).
After transmission, the larval form of the parasite migrates through the soft tissues and matures into an adult worm that lives in the subcutaneous tissue. Adult worms can be up to 7 cm long and may cause localized itching or a transient subconjunctival migration, which is painless but alarming to the patient.
Loiasis is usually asymptomatic, but severe symptoms such as Calabar swellings (recurrent angioedema), arthralgia, pruritus, and cardiac or respiratory complications can occur in heavy infections. Diagnosis is made by detecting microfilariae or adult worms in the blood, skin snips, or eye fluid. Treatment typically involves diethylcarbamazine citrate (DEC) therapy, but ivermectin and albendazole can also be used. Preventive measures include avoiding fly bites through the use of protective clothing, insect repellents, and bed nets.
Ebolavirus is a genus of viruses in the family Filoviridae, order Mononegavirales. It is named after the Ebola River in the Democratic Republic of Congo (formerly Zaire), where the virus was first identified in 1976. There are six species of Ebolavirus, four of which are known to cause disease in humans: Zaire ebolavirus, Sudan ebolavirus, Bundibugyo ebolavirus, and Tai Forest ebolavirus (formerly Cote d'Ivoire ebolavirus). The fifth species, Reston ebolavirus, is known to cause disease in non-human primates and pigs, but not in humans. The sixth and most recently identified species, Bombali ebolavirus, has not been associated with any human or animal diseases.
Ebolaviruses are enveloped, negative-sense, single-stranded RNA viruses that cause a severe and often fatal hemorrhagic fever in humans and non-human primates. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. Fruit bats of the Pteropodidae family are considered to be the natural host of Ebolavirus.
The symptoms of Ebolavirus disease (EVD) typically include fever, severe headache, muscle pain, weakness, fatigue, and sore throat, followed by vomiting, diarrhea, rash, impaired kidney and liver function, and in some cases, both internal and external bleeding. The case fatality rate of EVD is variable but has been historically high, ranging from 25% to 90% in past outbreaks depending on the species and the quality of medical care. There are no licensed specific treatments or vaccines available for EVD, although several promising candidates are currently under development.
Malaria, Falciparum is defined as a severe and often fatal form of malaria caused by the parasite Plasmodium falciparum. It is transmitted to humans through the bites of infected Anopheles mosquitoes. This type of malaria is characterized by high fever, chills, headache, muscle and joint pain, and vomiting. If left untreated, it can cause severe anemia, kidney failure, seizures, coma, and even death. It is a major public health problem in many tropical and subtropical regions of the world, particularly in Africa.